Literature DB >> 31189651

Deficiency in the phosphatase PHLPP1 suppresses osteoclast-mediated bone resorption and enhances bone formation in mice.

Anna M Mattson1, Dana L Begun1, David H H Molstad1, Margaret A Meyer1, Merry Jo Oursler2,3,4, Jennifer J Westendorf1,2, Elizabeth W Bradley5,6.   

Abstract

Enhanced osteoclast-mediated bone resorption and diminished formation may promote bone loss. Pleckstrin homology (PH) domain and leucine-rich repeat protein phosphatase 1 (Phlpp1) regulates protein kinase C (PKC) and other proteins in the control of bone mass. Germline Phlpp1 deficiency reduces bone volume, but the mechanisms remain unknown. Here, we found that conditional Phlpp1 deletion in murine osteoclasts increases their numbers, but also enhances bone mass. Despite elevating osteoclasts, Phlpp1 deficiency did not increase serum markers of bone resorption, but elevated serum markers of bone formation. These results suggest that Phlpp1 suppresses osteoclast formation and production of paracrine factors controlling osteoblast activity. Phlpp1 deficiency elevated osteoclast numbers and size in ex vivo osteoclastogenesis assays, accompanied by enhanced expression of proto-oncogene C-Fms (C-Fms) and hyper-responsiveness to macrophage colony-stimulating factor (M-CSF) in bone marrow macrophages. Although Phlpp1 deficiency increased TRAP+ cell numbers, it suppressed actin-ring formation and bone resorption in these assays. We observed that Phlpp1 deficiency increases activity of PKCζ, a PKC isoform controlling cell polarity, and that addition of a PKCζ pseudosubstrate restores osteoclastogenesis and bone resorption of Phlpp1-deficient osteoclasts. Moreover, Phlpp1 deficiency increased expression of the bone-coupling factor collagen triple helix repeat-containing 1 (Cthrc1). Conditioned growth medium derived from Phlpp1-deficient osteoclasts enhanced mineralization of ex vivo osteoblast cultures, an effect that was abrogated by Cthrc1 knockdown. In summary, Phlpp1 critically regulates osteoclast numbers, and Phlpp1 deficiency enhances bone mass despite higher osteoclast numbers because it apparently disrupts PKCζ activity, cell polarity, and bone resorption and increases secretion of bone-forming Cthrc1.
© 2019 Mattson et al.

Entities:  

Keywords:  Akt PKB; bone resorption; cell polarity; collagen triple helix repeat containing 1 (CTHRC1); colony-stimulating factor 1 receptor (CSF1R), mineralization; cytoskeleton; macrophage colony-stimulating factor (M-CSF); phosphatase; protein kinase C (PKC); protein kinase C zeta (PKC ζ)

Mesh:

Substances:

Year:  2019        PMID: 31189651      PMCID: PMC6682736          DOI: 10.1074/jbc.RA119.007660

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

Review 1.  Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm.

Authors:  Alexandra C Newton
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

Review 2.  Podosome and sealing zone: specificity of the osteoclast model.

Authors:  Pierre Jurdic; Frédéric Saltel; Anne Chabadel; Olivier Destaing
Journal:  Eur J Cell Biol       Date:  2005-10-24       Impact factor: 4.492

3.  Atypical protein kinase C-zeta is essential for delayed phagocytosis of Helicobacter pylori.

Authors:  Lee Ann H Allen; J Aaron Allgood
Journal:  Curr Biol       Date:  2002-10-15       Impact factor: 10.834

4.  M-CSF, c-Fms, and signaling in osteoclasts and their precursors.

Authors:  F Patrick Ross
Journal:  Ann N Y Acad Sci       Date:  2006-04       Impact factor: 5.691

5.  PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth.

Authors:  Tianyan Gao; Frank Furnari; Alexandra C Newton
Journal:  Mol Cell       Date:  2005-04-01       Impact factor: 17.970

6.  PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms.

Authors:  John Brognard; Emma Sierecki; Tianyan Gao; Alexandra C Newton
Journal:  Mol Cell       Date:  2007-03-23       Impact factor: 17.970

7.  Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice.

Authors:  B F Boyce; T Yoneda; C Lowe; P Soriano; G R Mundy
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

8.  Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts.

Authors:  Takashi Nakamura; Yuuki Imai; Takahiro Matsumoto; Shingo Sato; Kazusane Takeuchi; Katsuhide Igarashi; Yoshifumi Harada; Yoshiaki Azuma; Andree Krust; Yoko Yamamoto; Hiroshi Nishina; Shu Takeda; Hiroshi Takayanagi; Daniel Metzger; Jun Kanno; Kunio Takaoka; T John Martin; Pierre Chambon; Shigeaki Kato
Journal:  Cell       Date:  2007-09-07       Impact factor: 41.582

9.  Transgenic mice that express Cre recombinase in osteoclasts.

Authors:  W S M Chiu; J F McManus; A J Notini; A I Cassady; J D Zajac; R A Davey
Journal:  Genesis       Date:  2004-07       Impact factor: 2.487

10.  Atypical protein kinase C is involved in the evolutionarily conserved par protein complex and plays a critical role in establishing epithelia-specific junctional structures.

Authors:  A Suzuki; T Yamanaka; T Hirose; N Manabe; K Mizuno; M Shimizu; K Akimoto; Y Izumi; T Ohnishi; S Ohno
Journal:  J Cell Biol       Date:  2001-03-19       Impact factor: 10.539

View more
  4 in total

1.  Pleckstrin homology (PH) domain and Leucine Rich Repeat Phosphatase 1 (Phlpp1) Suppresses Parathyroid Hormone Receptor 1 (Pth1r) Expression and Signaling During Bone Growth.

Authors:  Samantha R Weaver; Earnest L Taylor; Elizabeth L Zars; Katherine M Arnold; Elizabeth W Bradley; Jennifer J Westendorf
Journal:  J Bone Miner Res       Date:  2021-02-08       Impact factor: 6.741

Review 2.  Serine/threonine phosphatases in osteoclastogenesis and bone resorption.

Authors:  Ismael Y Karkache; Jeyaram R Damodaran; David H H Molstad; Elizabeth W Bradley
Journal:  Gene       Date:  2020-12-16       Impact factor: 3.688

3.  Hdac3 deletion in myeloid progenitor cells enhances bone healing in females and limits osteoclast fusion via Pmepa1.

Authors:  David H H Molstad; Elizabeth Zars; Andrew Norton; Kim C Mansky; Jennifer J Westendorf; Elizabeth W Bradley
Journal:  Sci Rep       Date:  2020-12-11       Impact factor: 4.379

4.  The Effect of Alendronate on Osteoclastogenesis in Different Combinations of M-CSF and RANKL Growth Factors.

Authors:  Věra Hedvičáková; Radmila Žižková; Matěj Buzgo; Michala Rampichová; Eva Filová
Journal:  Biomolecules       Date:  2021-03-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.